Prevalence and mortality of patients with type 2 diabetes mellitus in 2010–2015 and mortality during the COVID pandemic (April 2020–March 2021)

Czech version

Authors: Jozef Lacka ¹; Emil Martinka ²; Petra Ištokovičová ³; Tamara Vraždová ³; Peter Jackuliak ⁴
Authors‘ workplace: JAL s. r. o., Trnava ¹; Národný endokrinologický a diabetologický ústav, n. o., Ľubochňa ²; DÔVERA zdravotná poisťovňa, a. s., Bratislava ³; V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava ⁴
Published in: Diab Obez 2023; 23(46): 91-100
Category:

Overview

Type 2 diabetes mellitus (DM2T) is a disease that is increasing in incidence and prevalence in all countries (with a large percentage of undiagnosed diabetes in the population to be reckoned with) and has a serious socioeconomic impact. The disease is accompanied by both acute and chronic complications, which translate not only into a poorer quality of life but also significantly increased morbidity and mortality, especially if it is not adequately treated (life expectancy of patients is reduced by more than 25–30 %). However, DM2T as a cause of patient death is very rarely reported by the examining physician. Also, patient mortality data is not part of the reporting to the National Center for Health Information. Thus, the data reported on the health care provided is the most accurate data available on the diagnosis, treatment of DM and its complications. No study on the prevalence and mortality of patients treated for DM2T has been carried out in Slovakia so far. Therefore, this retrospective epidemiological analysis was designed in collaboration between clinical and outpatient clinics and the health insurance company Dôvera, using data from insured patients with DM2T during period 2010–2015 and during the COVID-19 pandemic in April/2020–March/2021, to evaluate the level of mortality from DM2T in these insured patients.

Keywords:

morbidity – mortality – COVID-19 pandemic – type 2 diabetes mellitus (T2D) – retrospective epidemiologic analysis

Sources

Mokáň M, Martinka E, nGalajda P a kol. Diabetes mellitus a vybrané metabolické ochorenia. Vydavateľstvo P + M: Turany 2008. ISBN 978–80–969713–9-8.
Prezentácia XXXIII. diabetologické dni s medzinárodnou účasťou. Štrbské pleso, 25.-27. máj 2023. Dostupné z WWW: <https://diaslovakia.sk/content/xxxiii-diabetologicke-dni-medzinarodnou-ucastou-strbske-pleso-25–27-maj-2023>.
Demografie. Úmrtnost. Dostupné z WWW: <http://www.demografie.info/?cz_umrtnoststandard>.
Mokáň M, Galajda P , Prídavková et al. Prevalencia diabetes mellitus a metabolického syndrómu na Slovensku. Diab Obez 2006; 6(12): 10–17.
Clarke PM, Gray AM, Briggs A et al. UK Prospective Diabetes Study (UKDPS) Group. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 2004; 47(10): 1747–1759. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–004–1527-z>.
Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30(3): 123–131. Dostupné z DOI: <http://dx.doi.org/10.1007/BF00274216>.
Roper NA, Bilous RW, Kelly WF et al. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ 2001; 322(7299): 1389–1393. Dostupné z DOI: <http://dx.doi.org/10.1136/bmj.322.7299.1389>.
Tan HH, McAlpine RR, James P et al. Diagnosis of type 2 diabetes at an older age: effect on mortality in men and women. Diabetes Care 2004; 27(12): 2797–2799. Dostupné z DOI: <http://dx.doi.org/10.2337/diacare.27.12.2797>.
Tan HH, McAlpine RR, James P et al. Diagnosis of type 2 diabetes at an older age: effect on mortality in men and women. Diabetes Care 2004; 27(12): 2797–2799. Dostupné z DOI: <http://dx.doi.org/10.2337/diacare.27.12.2797>.
Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971–1993. Diabetes Care 1998; 21(7): 1138–1145. Dostupné z DOI: <http://dx.doi.org/10.2337/diacare.21.7.1138>.
Janíčková Žďárská D, Brož J, Piťhová P et al. Kvalita péče o pacienty s diabetem v České republice. Analýza dat VZP. Forum Diab 2016: 5(2): 70–75.
Kaminska H, Szarpak L, Kosior D et al. Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis. Acta Diabetol 2021; 58(8): 1101–1110. Dostupné z DOI: <http://dx.doi.org/10.1007/s00592–021–01701–1>.
Holman N, Knighton R, Kar R et al. Riskfactors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol 2020; 8(10): 823–833. Dostupné z DOI: <http://dx.doi.org/10.1016/S2213–8587(20)30271–0>.
WoolF SH, Chapman A, Sabo RT et al. Excess deaths from COVID-19 and other causes in the US (March 1, 2020, to January 2, 2021). JAMA, 2021, 325(17): 1786–1789. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2021.5199>.
Gregg EW, Sophiea MK, Weldegiorgius M. Diabetes and COVID-19: Population Impact 18 Months into the Pandemic. Diabetes Care 2021; 44(9): 1916–1923. Dostupné z DOI: <MARTIhttps://doi.org/10.2337/dci21–0001>.